Rights and permissions
About this article
Cite this article
Reduction in asthma costs with oral leukotriene antagonist. Pharmacoecon. Outcomes News 31, 12 (1995). https://doi.org/10.1007/BF03272850
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03272850